Medpace EVP of Operations Susan Burwig Exercises Stock Options Ahead of Expiration

Executive Summary

On October 7, 2026, Susan E. Burwig, Executive Vice President of Operations at Medpace Holdings, Inc. ($MEDP), exercised employee stock options to acquire 2,000 shares of common stock at an exercise price of $166.73 per share, representing an aggregate exercise value of $333,460. Notably, no concurrent open-market sales were reported in the filing, increasing her direct ownership to 67,984 shares.

Key Transaction Details

• Security: Common Stock
• Nature of Transaction: Option Exercise (Transaction Code M)
• Shares Acquired: 2,000 shares
• Exercise Price: $166.73
• Total Investment / Cost: $333,460.00
• Beneficial Ownership Post-Transaction: 67,984 direct shares (along with 6,028 remaining derivative option awards)
• Derivative Expiration: The options exercised were set to expire on October 27, 2026, approximately 20 days after the exercise date.

Significance & Market Context

The transaction reflects routine equity award administration driven by the option grant's upcoming expiration on October 27, 2026. Because the executive held the acquired shares rather than executing a cashless exercise-and-sell, the move avoids near-term selling pressure and demonstrates continued long-term alignment with shareholders. Given the routine expiration timeline and modest transaction size relative to her existing holdings (an increase of ~3.0%), the overall trading significance is rated Low.